Organoiridium complexes: Anticancer agents and catalysts

Accounts of Chemical Research

Volumn 47, Issue 4, 2014, Pages 1174-1185

  Liu, Zhe ^a   Sadler, Peter J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IRIDIUM; LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE; ORGANOMETALLIC COMPOUND; PYRIDINE; PYRIDINE DERIVATIVE;

CATALYSIS; CHEMISTRY; HUMAN; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CATALYSIS; HUMANS; IRIDIUM; LIGANDS; NAD; ORGANOMETALLIC COMPOUNDS; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84898879350     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar400266c     Document Type: Article

References (69)

1. Jollie, D. Platinum 2008; Johnson Matthey: Hertfordshire, U.K.; 2008; pp 42-43
2. Sunley, G. J.; Watson, D. J. High productivity methanol carbonylation catalysis using iridium: The Cativa process for the manufacture of acetic acid Catal. Today 2000, 58, 293-307
3. 5X (X = CN, F): Formation of Diiridium(II) Complexes Organometallics 2013, 32, 1053-1059
4. +, Related to a Water-Oxidation Catalyst Organometallics 2011, 30, 965-973
5. Gilbert, T. M.; Bergman, R. G. Preparation and reactions of tetrahydrido(pentamethylcyclopentadienyl)iridium: a novel iridium(V) polyhydride Organometallics 1983, 2, 1458-1460
6. Iridium Catalysis (Topics in Organometallic Chemistry); Andersson, P. G., Ed.; Springer-Verlag: Berlin, 2011; Vol. 34.
7. 2 and a proton-switchable iridium catalyst in aqueous media under mild temperatures and pressures Nat. Chem. 2012, 4, 383-388
8. Ahuja, R.; Punji, B.; Findlater, M.; Supplee, C.; Schinski, W.; Brookhart, M.; Goldman, A. S. Catalytic dehydroaromatization of n-alkanes by pincer-ligated iridium complexes Nat. Chem. 2011, 3, 167-171
9. Goldman, A. S.; Roy, A. H.; Huang, Z.; Ahuja, R.; Schinski, W.; Brookhart, M. Catalytic Alkane Metathesis by Tandem Alkane Dehydrogenation- Olefin Metathesis Science 2006, 312, 257-261
10. Lightfoot, A.; Schnider, P.; Pfaltz, A. Enantioselective Hydrogenation of Olefins with Iridium-Phosphanodihydrooxazole Catalysts Angew. Chem., Int. Ed. 1998, 37, 2897-2899
11. Savini, A.; Bellachioma, G.; Ciancaleoni, G.; Zuccaccia, C.; Zuccaccia, D.; Macchioni, A. Iridium(III) molecular catalysts for water oxidation: the simpler the faster Chem. Commun. 2010, 46, 9218-9219
12. Blakemore, J. D.; Schley, N. D.; Olack, G. W.; Incarvito, C. D.; Brudvig, G. W.; Crabtree, R. H. Anodic deposition of a robust iridium-based water-oxidation catalyst from organometallic precursors Chem. Sci. 2011, 2, 94-98
13. Lo, K. K.-W.; Li, S. P.-Y.; Zhang, K. Y. Development of luminescent iridium(III) polypyridine complexes as chemical and biological probes New J. Chem. 2011, 35, 265-287
14. Leung, C.-H.; Zhong, H.-J.; Chan, D. S.-H.; Ma, D.-L. Bioactive iridium and rhodium complexes as therapeutic agents Coord. Chem. Rev. 2013, 257, 1764-1776
15. Wilbuer, A.; Vlecken, D. H.; Schmitz, D. J.; Kräling, K.; Harms, K.; Bagowski, C. P.; Meggers, E. Iridium Complex with Antiangiogenic Properties Angew. Chem., Int. Ed. 2010, 49, 3839-3842
16. Geldmacher, Y.; Oleszak, M.; Sheldrick, W. S. Rhodium(III) and iridium(III) complexes as anticancer agents Inorg. Chim. Acta 2012, 393, 84-102
17. Gasser, G.; Ott, I.; Metzler-Nolte, N. Organometallic Anticancer Compounds J. Med. Chem. 2011, 54, 3-25
18. Giraldi, T.; Sava, G.; Mestroni, G.; Zassinovich, G.; Stolfa, D. Antitumour Action of Rhodium (I) and Iridium (I) Complexes Chem.-Biol. Interact. 1978, 22, 231-238
19. Sava, G.; Zorzet, S.; Perissin, L.; Mestroni, G.; Zassinovich, G.; Bontempi, A. Coordination Metal Complexes of Rh(I), Ir(I) and Ru(II): Recent Advances on Antimetastatic Activity on Solid Mouse Tumors Inorg. Chim. Acta 1987, 137, 69-71
20. Bruijnincx, P. C. A.; Sadler, P. J. In Advances in Inorganic Chemistry; Rudi van, E.; Hubbard, C. D., Eds.; Academic Press: New York, 2009; Vol. 61, pp 1-62.
21. 3-henylallyl Complexes Bull. Korean Chem. Soc. 1997, 18, 402-405
22. Liu, Z.; Habtemariam, A.; Pizarro, A. M.; Fletcher, S. A.; Kisova, A.; Vrana, O.; Salassa, L.; Bruijnincx, P. C. A.; Clarkson, G. J.; Brabec, V.; Sadler, P. J. Organometallic Half-Sandwich Iridium Anticancer Complexes J. Med. Chem. 2011, 54, 3011-3026
23. Liu, Z.; Salassa, L.; Habtemariam, A.; Pizarro, A. M.; Clarkson, G. J.; Sadler, P. J. Contrasting Reactivity and Cancer Cell Cytotoxicity of Isoelectronic Organometallic Iridium(III) Complexes Inorg. Chem. 2011, 50, 5777-5783
24. Liu, Z.; Habtemariam, A.; Pizarro, A. M.; Clarkson, G. J.; Sadler, P. J. Organometallic Iridium(III) Cyclopentadienyl Anticancer Complexes Containing C,N-Chelating Ligands Organometallics 2011, 30, 4702-4710
25. Pizarro, A. M.; Habtemariam, A.; Sadler, P. J. In Medicinal Organometallic Chemistry (Topics in Organometallic Chemistry), 1 st ed.; Jaouen, G.; Metzler-Nolte, N., Eds.; Springer-Verlag: Heidelberg, Germany, 2010; Vol. 32; pp 21-56.
26. Graf, N.; Lippard, S. J. Redox activation of metal-based prodrugs as a strategy for drug delivery Adv. Drug Delivery Rev. 2012, 64, 993-1004
27. Helm, L.; Merbach, A. E. Water Exchange on Metal Ions: Experiments and Simulations Coord. Chem. Rev. 1999, 187, 151-181
28. 4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties Clin. Exp. Metastasis 1992, 10, 273-280
29. 2], (II), Complexes J. Inorg. Biochem. 2003, 95, 37-46
30. 5-Pentamethylcyclopentadienyl Anion; A-B = Bidentate N,N or N,O Ligand) Eur. J. Inorg. Chem. 2001, 2001, 1361-1369
31. Noffke, A. L.; Habtemariam, A.; Pizarro, A. M.; Sadler, P. J. Designing organometallic compounds for catalysis and therapy Chem. Commun. 2012, 48, 5219-5246
32. Habtemariam, A.; Liu, Z.; Soldevila, J. J.; Pizarro, A. M.; Sadler, P. J. Novel Iridium/Rhodium Anti-Cancer Compounds. PCT Int. Appl., WO/2011/148124, 2011; 88p.
33. Hearn, J. M.; Romero-Canelón, I.; Qamar, B.; Liu, Z.; Hands-Portman, I.; Sadler, P. J. Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis ACS Chem. Biol. 2013, 8, 1335-1343
34. Liu, Z.; Romero-Canelón, I.; Qamar, B.; Hearn, J. M.; Habtemariam, A.; Barry, N. P. E.; Pizarro, A. M.; Clarkson, G. J.; Sadler, P. J. The Potent Oxidant Anticancer Activity of Organoiridium Catalysts. Angew. Chem., Int. Ed. 2014, DOI: 1010.1002/anie.201311161.
35. 5-pentamethylcyclopentadienyl)-iridium(III)- dipyridoquinoxaline and -dipyridophenazine Complexes J. Organomet. Chem. 2007, 692, 1300-1309
36. n+ (dppz = dipyrido[3,2-a:2′,3′-c]phenazine), n = 1-3 J. Chem. Soc., Dalton Trans. 2002, 3664-3673
37. Ruiz, J.; Rodriguez, V.; Cutillas, N.; Samper, K. G.; Capdevila, M.; Palacios, O.; Espinosa, A. Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA Dalton Trans. 2012, 41, 12847-12856
38. Wirth, S.; Rohbogner, C.; Cieslak, M.; Kazmierczak-Baranska, J.; Donevski, S.; Nawrot, B.; Lorenz, I.-P. Rhodium(III) and Iridium(III) Complexes with 1,2-naphthoquinone-1-oximate as a Bidentate Ligand: Synthesis, Structure, and Biological Activity J. Biol. Inorg. Chem. 2010, 15, 429-440
39. 5-pentamethylcyclopentadienyl Rhodium(III) and Iridium(III) Complexes with Quinolin-8-ol and Their Cytostatic Activity Polyhedron 2010, 29, 1653-1659
40. Gras, M.; Therrien, B.; Süss-Fink, G.; Casini, A.; Edafe, F.; Dyson, P. J. Anticancer Activity of New Organo-Ruthenium, Rhodium and Iridium Complexes Containing the 2-(pyridine-2-yl)thiazole N,N-chelating Ligand J. Organomet. Chem. 2010, 695, 1119-1125
41. Lucas, S. J.; Lord, R. M.; Wilson, R. L.; Phillips, R. M.; Sridharan, V.; McGowan, P. C. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents Dalton Trans. 2012, 41, 13264-13266
42. Wang, F.; Habtemariam, A.; van der Geer, E. P. L.; Fernández, R.; Melchart, M.; Deeth, R. J.; Aird, R.; Guichard, S.; Fabbiani, F. P. A.; Lozano-Casal, P.; Oswald, I. D. H.; Jodrell, D. I.; Parsons, S.; Sadler, P. J. Controlling Ligand Substitution Reactions of Organometallic Complexes: Tuning Cancer Cell Cytotoxicity Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 18269-18274
43. Trachootham, D.; Alexandre, J.; Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discovery 2009, 8, 579-591
44. Betanzos-Lara, S.; Liu, Z.; Habtemariam, A.; Pizarro, A. M.; Qamar, B.; Sadler, P. J. Organometallic Ruthenium and Iridium Transfer-Hydrogenation Catalysts Using Coenzyme NADH as a Cofactor Angew. Chem., Int. Ed. 2012, 51, 3897-3900
45. Liu, Z.; Deeth, R. J.; Butler, J. S.; Habtemariam, A.; Newton, M. E.; Sadler, P. J. Reduction of Quinones by NADH Catalyzed by Organoiridium Complexes Angew. Chem., Int. Ed. 2013, 52, 4194-4197
46. Casini, A.; Edafe, F.; Erlandsson, M.; Gonsalvi, L.; Ciancetta, A.; Re, N.; Ienco, A.; Messori, L.; Peruzzini, M.; Dyson, P. J. Rationalization of The Inhibition Activity of Structurally Related Organometallic Compounds Against the Drug Target Cathepsin B by DFT Dalton Trans. 2010, 39, 5556-5563
47. Amouri, H.; Moussa, J.; Renfrew, A. K.; Dyson, P. J.; Rager, M. N.; Chamoreau, L.-M. Discovery, Structure, and Anticancer Activity of an Iridium Complex of Diselenobenzoquinone Angew. Chem., Int. Ed. 2010, 49, 7530-7533
48. Kastl, A.; Wilbuer, A.; Merkel, A. L.; Feng, L.; Di Fazio, P.; Ocker, M.; Meggers, E. Dual anticancer activity in a single compound: visible-light- induced apoptosis by an antiangiogenic iridium complex Chem. Commun. 2012, 48, 1863-1865
49. Ali Nazif, M.; Bangert, J.-A.; Ott, I.; Gust, R.; Stoll, R.; Sheldrick, W. S. Dinuclear Organoiridium(III) mono- and bis-intercalators with Rigid Bridging Ligands: Synthesis, Cytotoxicity and DNA Binding J. Inorg. Biochem. 2009, 103, 1405-1414
50. Payne, R.; Govender, P.; Therrien, B.; Clavel, C. M.; Dyson, P. J.; Smith, G. S. Neutral and cationic multinuclear half-sandwich rhodium and iridium complexes coordinated to poly(propyleneimine) dendritic scaffolds: Synthesis and cytotoxicity J. Organomet. Chem. 2013, 729, 20-27
51. Gupta, G.; Garci, A.; Murray, B. S.; Dyson, P. J.; Fabre, G.; Trouillas, P.; Giannini, F.; Furrer, J.; Suss-Fink, G.; Therrien, B. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes Dalton Trans. 2013, 42, 15457-15463
52. Johnpeter, J. P.; Gupta, G.; Kumar, J. M.; Srinivas, G.; Nagesh, N.; Therrien, B. Biological Studies of Chalcogenolato-Bridged Dinuclear Half-Sandwich Complexes Inorg. Chem. 2013, 52, 13663-13673
53. Lee, P.-K.; Liu, H.-W.; Yiu, S.-M.; Louie, M.-W.; Lo, K. K.-W. Luminescent cyclometallated iridium(III) bis(quinolylbenzaldehyde) diimine complexes-synthesis, photophysics, electrochemistry, protein cross-linking properties, cytotoxicity and cellular uptake Dalton Trans. 2011, 40, 2180-2189
54. Leung, K.-H.; He, H.-Z.; Ma, V. P.-Y.; Zhong, H.-J.; Chan, D. S.-H.; Zhou, J.; Mergny, J.-L.; Leung, C.-H.; Ma, D.-L. Detection of base excision repair enzyme activity using a luminescent G-quadruplex selective switch-on probe Chem. Commun. 2013, 49, 5630-5632
55. Leung, K.-H.; He, H.-Z.; Ma, V. P.-Y.; Chan, D. S.-H.; Leung, C.-H.; Ma, D.-L. A luminescent G-quadruplex switch-on probe for the highly selective and tunable detection of cysteine and glutathione Chem. Commun. 2013, 49, 771-773
56. Ma, D.-L.; He, H.-Z.; Leung, K.-H.; Zhong, H.-J.; Chan, D. S.-H.; Leung, C.-H. Label-free luminescent oligonucleotide-based probes Chem. Soc. Rev. 2013, 42, 3427-3440
57. Ruiz, J.; Vicente, C.; de Haro, C.; Bautista, D. Novel Bis-C,N-Cyclometalated Iridium(III) Thiosemicarbazide Antitumor Complexes: Interactions with Human Serum Albumin and DNA, and Inhibition of Cathepsin B Inorg. Chem. 2013, 52, 974-982
58. Lo, K. K.-W.; Zhang, K. Y. Iridium(III) complexes as therapeutic and bioimaging reagents for cellular applications RSC Adv. 2012, 2, 12069-12083
59. Gao, R.; Ho, D. G.; Hernandez, B.; Selke, M.; Murphy, D.; Djurovich, P. I.; Thompson, M. E. Bis-cyclometalated Ir(III) Complexes as Efficient Singlet Oxygen Sensitizers J. Am. Chem. Soc. 2002, 124, 14828-14829
60. Li, S. P.-Y.; Lau, C. T.-S.; Louie, M.-W.; Lam, Y.-W.; Cheng, S. H.; Lo, K. K.-W. Mitochondria-targeting cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity Biomaterials 2013, 34, 7519-7532
61. Moromizato, S.; Hisamatsu, Y.; Suzuki, T.; Matsuo, Y.; Abe, R.; Aoki, S. Design and Synthesis of a Luminescent Cyclometalated Iridium(III) Complex Having N,N-Diethylamino Group that Stains Acidic Intracellular Organelles and Induces Cell Death by photoirradiation Inorg. Chem. 2012, 51, 12697-12706
62. Leung, C.-H.; Zhong, H.-J.; Yang, H.; Cheng, Z.; Chan, D. S.-H.; Ma, V. P.-Y.; Abagyan, R.; Wong, C.-Y.; Ma, D.-L. A Metal-Based Inhibitor of Tumor Necrosis Factor-α Angew. Chem., Int. Ed. 2012, 51, 9010-9014
63. Shao, F.; Elias, B.; Lu, W.; Barton, J. K. Synthesis and Characterization of Iridium(III) Cyclometalated Complexes with Oligonucleotides: Insights into Redox Reactions with DNA Inorg. Chem. 2007, 46, 10187-10199
64. Liu, S.; Rebros, M.; Stephens, G.; Marr, A. C. Adding Value to Renewables: a One Pot Process Combining Microbial Cells and Hydrogen Transfer Catalysis to Utilise Waste Glycerol from Biodiesel Production Chem. Commun. 2009, 2308-2310
65. Canivet, J.; Süss-Fink, G.; Štěpnička, P. Water-Soluble Phenanthroline Complexes of Rhodium, Iridium and Ruthenium for the Regeneration of NADH in the Enzymatic Reduction of Ketones Eur. J. Inorg. Chem. 2007, 4736-4742
66. Meiners, J.; Scheibel, M. G.; Lemée-Cailleau, M.-H.; Mason, S. A.; Boeddinghaus, M. B.; Fässler, T. F.; Herdtweck, E.; Khusniyarov, M. M.; Schneider, S. Square-Planar Iridium(II) and Iridium(III) Amido Complexes Stabilized by a PNP Pincer Ligand Angew. Chem., Int. Ed. 2011, 50, 8184-8187
67. Heinekey, D. M.; Fine, D. A.; Barnhart, D. Protonation of Metal-Metal Bonds in Dinuclear Iridium Complexes: Consequences for Structure and Reactivity Organometallics 1997, 16, 2530-2538
68. Quinto, T.; Schwizer, F.; Zimbron, J. M.; Morina, A.; Köhler, V.; Ward, T. R. Expanding the Chemical Diversity in Artificial Imine Reductases Based on the Biotin-Streptavidin Technology ChemCatChem. 2014, 10.1002/cctc.201300825
69. Köhler, V.; Wilson, Y. M.; Dürrenberger, M.; Ghislieri, D.; Churakova, E.; Quinto, T.; Knörr, L.; Häussinger, D.; Hollmann, F.; Turner, N. J.; Ward, T. R. Synthetic cascades are enabled by combining biocatalysts with artificial metalloenzymes Nat. Chem. 2013, 5, 93-99